Víctor M. Villalobos
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Plant tissue culture and regeneration, CAR-T cell therapy research, Peptidase Inhibition and Analysis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers(2019)575 cited
- → The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients(2020)460 cited
- → Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial(2020)438 cited
- → Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study(2020)389 cited
- → NCCN Guidelines Insights: Bone Cancer, Version 2.2017(2017)293 cited
- → Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma(2020)153 cited